This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2012-2016.
Location History:
- Fortville, IN (US) (2012 - 2016)
- Fishers, IN (US) (2013 - 2016)
Company Filing History:
Years Active: 2012-2016
Title: Ryan James Darling: Innovator in Medical Treatments
Introduction
Ryan James Darling is a prominent inventor based in Fishers, IN (US). He has made significant contributions to the field of medicine, particularly in the development of treatments for various health conditions. With a total of 9 patents to his name, Darling's work is recognized for its innovative approach to addressing complex medical issues.
Latest Patents
Among his latest patents is a groundbreaking method to treat migraines using CGRP antibodies. This invention provides human engineered calcitonin gene-related peptide (CGRP) antibodies or antigen-binding fragments thereof. Additionally, it outlines the use of these antibodies for the treatment of osteoarthritis pain. Another notable patent is related to fibroblast growth factor 21 variants, which includes pharmacologically potent and stable human FGF21 variants. This invention also encompasses pharmaceutical compositions comprising FGF21 variants and methods for treating type 2 diabetes, obesity, dyslipidemia, and metabolic syndrome using such variants.
Career Highlights
Ryan James Darling is currently associated with Eli Lilly and Company, where he continues to innovate and contribute to the field of pharmaceuticals. His work at Eli Lilly has positioned him as a key player in the development of new medical treatments.
Collaborations
Darling has collaborated with notable colleagues, including Craig Duane Dickinson and David A Driver. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Ryan James Darling's contributions to medical innovation are significant and impactful. His patents reflect a commitment to improving health outcomes through advanced treatments. His work continues to inspire future innovations in the medical industry.